ELF5 and breast carcinoma: In 2012 we proposed that luminal breast cancer cells may retain some of the cell-fate plasticity of the progenitor cell population seen in normal development, and that the expressed cancer phenotype results, at least in part, from the balance between ELF5 and ER influence [19].